Home › NDC Lookup › RxCUI directory › RxCUI 151226

Topiramate 50 MG Oral Tablet — RxCUI 151226

RxNorm drug concept · Semantic clinical drug
RxCUI 151226 Semantic clinical drug · SCD ● Current RxNorm concept 112 FDA products 310 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI151226
Official nameTopiramate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped112
Package NDCs mapped310
Reported Medicaid activity (SDUD)2,644,454 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Topiramate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
📖 Read our full Topiramate guide →

🕸️ Concept Web — How Topiramate 50 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Topiramate 50 MG Oral Tablet RxCUI 151226

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Topiramate 38404
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Topamax 220343
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Topiramate Oral Tablet 374166
    • Topiramate Oral Product 1162749
    • Topiramate Pill 1162750
    • Topiramate Oral Tablet [Topamax] 367661
    • Topamax Oral Product 1177986
    • Topamax Pill 1177987
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Topiramate 50 MG SCDC · 335759
  • Topiramate Oral Tablet SCDF · 374166
  • Topiramate Oral Product SCDG · 1162749
  • Topiramate Pill SCDG · 1162750

Brand-Name Concepts

  • Topiramate 50 MG Oral Tablet [Topamax] SBD · 151227
  • Topiramate 50 MG [Topamax] SBDC · 564941
  • Topiramate Oral Tablet [Topamax] SBDF · 367661
  • Topamax Oral Product SBDG · 1177986
  • Topamax Pill SBDG · 1177987
  • Topamax BN · 220343

📦 FDA Products & Package NDCs

112 products · 310 package NDCs
310 package NDCs map to RxCUI 151226 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80425-0214-01 30 TABLET, FILM COATED in 1 BOTTLE (80425-0214-1) Topiramate Advanced Rx Pharmacy of Tennessee, LLC 2023-01-03
80425-0214-02 60 TABLET, FILM COATED in 1 BOTTLE (80425-0214-2) Topiramate Advanced Rx Pharmacy of Tennessee, LLC 2023-01-03
80425-0214-03 90 TABLET, FILM COATED in 1 BOTTLE (80425-0214-3) Topiramate Advanced Rx Pharmacy of Tennessee, LLC 2023-01-03
80425-0495-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80425-0495-1) topiramate Advanced Rx of Tennessee, LLC 2025-03-20
80425-0495-02 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80425-0495-2) topiramate Advanced Rx of Tennessee, LLC 2025-03-20
80425-0495-03 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80425-0495-3) topiramate Advanced Rx of Tennessee, LLC 2025-03-20
82009-0135-05 500 TABLET, FILM COATED in 1 BOTTLE (82009-135-05) topiramate Quallent Pharmaceuticals Health LLC 2023-07-24
82009-0136-05 500 TABLET, FILM COATED in 1 BOTTLE (82009-136-05) topiramate Quallent Pharmaceuticals Health LLC 2023-07-24
82009-0137-05 500 TABLET, FILM COATED in 1 BOTTLE (82009-137-05) topiramate Quallent Pharmaceuticals Health LLC 2023-07-24
83008-0011-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (83008-011-30) topiramate Quality Care Products, LLC 2023-03-24
Observed labelers: Bryant Ranch Prepack (33) · Cipla USA Inc. (24) · Proficient Rx LP (23) · Sun Pharmaceutical Industries, Inc. (22) · A-S Medication Solutions (17) · Unichem Pharmaceuticals (USA), Inc. (16) · +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.